Protalix BioTherapeutics
PLX
#8930
Rank
NZ$0.32 B
Marketcap
NZ$4.07
Share price
0.42%
Change (1 day)
55.82%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2026 (TTM): NZ$36.02 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are NZ$76.38 Million. In 2025 the company made an earning of -NZ$7.32 Million a decrease over its 2024 earnings that were of NZ$8.95 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$36.02 M-592.74%
2025 -NZ$7.32 Million-181.6%
2024 NZ$8.95 M-55.62%
2023 NZ$20.18 M-199.05%
2022 -NZ$20.39 Million-40.38%
2021 -NZ$34.2 Million-732.31%
2020 NZ$5.4 M-130.53%
2019 -NZ$17.71 Million189.85%
2018 -NZ$6.11 Million-95.29%
2017 -NZ$0.13 Billion308.12%
2016 -NZ$31.8 Million-32.37%
2015 -NZ$47.02 Million10.11%
2014 -NZ$42.7 Million-7.59%
2013 -NZ$46.21 Million
2011 -NZ$53.51 Million-19.39%
2010 -NZ$66.38 Million20.87%
2009 -NZ$54.92 Million32.26%
2008 -NZ$41.52 Million-5.46%
2007 -NZ$43.92 Million
2004 -NZ$0.29 Million12.35%
2003 -NZ$0.26 Million-11.1%
2002 -NZ$0.29 Million-57.03%
2001 -NZ$0.67 Million1.03%
2000 -NZ$0.66 Million-53.22%
1999 -NZ$1.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$18.19 B 50,808.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.37 B 3,739.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$0.32 M-99.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.90 B 10,816.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel